Cargando…
Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review
OBJECTIVE: This study evaluated the effectiveness and safety of subanesthetic doses of ketamine using an off-label, transmucosal administration route in patients with treatment-resistant depression. METHODS: A retrospective chart review was conducted to identify patients who met the inclusion criter...
Autores principales: | Nguyen, Linda, Marshalek, Patrick J, Weaver, Cory B, Cramer, Kathy J, Pollard, Scott E, Matsumoto, Rae R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610773/ https://www.ncbi.nlm.nih.gov/pubmed/26508862 http://dx.doi.org/10.2147/NDT.S88569 |
Ejemplares similares
-
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
por: Wohleb, Eric S., et al.
Publicado: (2017) -
An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022) -
Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
por: Zhang, Melvyn W., et al.
Publicado: (2016) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013) -
PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
por: Domino, Edward F.
Publicado: (2016)